Adial Pharmaceuticals, Inc. Form ARS: Annual report to security holders
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2026-08-24: Form ARS; Period of report 2025-12-31; Description FORM ARS; Document ea030303101-ars_adial.pdf.
- 2025-06-10: Form ARS; Period of report 2024-12-31; Description FORM ARS; Document ea024412901-ars_adialph.pdf.
- 2024-09-30: Form ARS; Period of report 2023-12-31; Description FORM ARS; Document ea0212489-03.pdf.
- 2023-10-02: Form ARS; Period of report 2022-12-31; Description ANNUAL REPORT; Document fars2023_adialpharma.pdf.
| Filed | Form | Period of report | Description | Document |
|---|---|---|---|---|
| 2026-08-24 | ARS | 2025-12-31 | FORM ARS | ea030303101-ars_adial.pdf |
| 2025-06-10 | ARS | 2024-12-31 | FORM ARS | ea024412901-ars_adialph.pdf |
| 2024-09-30 | ARS | 2023-12-31 | FORM ARS | ea0212489-03.pdf |
| 2023-10-02 | ARS | 2022-12-31 | ANNUAL REPORT | fars2023_adialpharma.pdf |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |